Skip to content

Effectiveness of therapeutic ultrasound when used as an adjuvant to pharmacotherapy in Temporomandibular joint disorders.

Efficacy of therapeutic ultrasound as an adjuvant to pharmacotherapy in temporomandibular joint disorders(TMDs)- A comparative clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043181
Enrollment
30
Registered
2022-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: ultrasound therapy: ultrasound therapy will be given to the patients with TMDs 2 times a week for 4 weeks Control Intervention1: pharmacotherapy -ibuprpfen, chlorzoxazone, paracetemol:

Sponsors

SAI SRI KOLLI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: those wh%o are diagnosed with TMDs under research diagnostic criteria (RDC) subjects who are willing to give their consent to participate in the study will be included

Exclusion criteria

Exclusion criteria: 1. Subjects with morphological alterations of TMJ. 2 .Subjects who have abrasions or skin lesions at the site of ultrasound application. 3.Subjects with systemic disorders like ischemia, neuropathies ,pacemakers and cardiac arrythmias. 4. Subjects with prior TMJ surgery. 5. Subjects who had undergone physical therapy for TMDs in the previous 3 months.

Design outcomes

Primary

MeasureTime frame
â?¢ To assess the efficacy of ultrasound therapy in TMDs. â?¢ To assess the efficacy of pharmacotherapy in TMDs â?¢ To assess the efficacy of combined pharmacotherapy and ultrasound in TMDs. Timepoint: baseline 3 months

Secondary

MeasureTime frame
â?¢ To assess the efficacy of ultrasound therapy in TMDs. â?¢ To assess the efficacy of pharmacotherapy in TMDs â?¢ To assess the efficacy of combined pharmacotherapy and ultrasound in TMDs. Timepoint: baseline 3 months

Countries

India

Contacts

Public ContactSAI SRI KOLLI

Sibar Institute Dental Sciences

purnachandraraonaik@gmail.com9989857600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026